Clinical Trials List
2014-03-01 - 2017-12-31
Phase III
Terminated13
ICD-10E11.9
Type 2 diabetes mellitus without complications
ICD-10E13.9
Other specified diabetes mellitus without complications
ICD-9250.00
Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 黃國欽 Division of Endocrinology
- Chih Hsueh Lin Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- I-TE LEE Division of Endocrinology
- 潘泓智 Division of Endocrinology
- 張心玫 Division of Endocrinology
- JUN-SING WANG Division of Endocrinology
- 梁凱偉 Division of Endocrinology
- 李昂澤 Division of Endocrinology
- 傅家保 Division of Endocrinology
- 陳柏勳 Division of Endocrinology
- 林時逸 Division of Endocrinology
- 李佳霖 Division of Endocrinology
- 郭怡婷 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wen-Chung Yu Division of Cardiovascular Diseases
- Ju-Pin Pan Division of Cardiovascular Diseases
- Kang-Ling Wang Division of Cardiovascular Diseases
- Tse-Min Lu Division of Cardiovascular Diseases
- 林幸榮 Division of Cardiovascular Diseases
- Shih-Hsien Sung Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳偉哲 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳振宇 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林志展 Division of Endocrinology
- 吳達仁 Division of Endocrinology
- Cheng-Han Lee Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 黃莉棋 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Jui-Hung Sun Division of Endocrinology
- 陳維志 Division of Endocrinology
- Jhao-Shan Hwang Division of Endocrinology
- Wen-Cong Lu Division of Endocrinology
- 林承緯 Division of Endocrinology
- Chih-Yiu Tsai Division of Endocrinology
- Shu-Fu Lin Shu-Fu Lin Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳偉哲 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
180 participants
-
Global
5700 participants
